EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Pretreatment Computed Tomography–Defined Sarcopenia, Treatment-Associated Muscle Loss, and Survival in Patients With Cervical Cancer: A Systematic Review and Meta-Analysis

Mengxing Tian, Huiting Xu, Hongbin Wang, Huifen Wang, Zhu Dai, Chenchen Ding, Huan Guo, Xin Jin iD

Nutrition Reviews · 01.05.2025 · 83 (5) · 797-808

DOI: 10.1093/nutrit/nuae130 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, online erschienen am 28.09.2024. Verfasst von Mengxing Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, …. Hauptthemen laut MEDLINE: Sarcopenia, Uterine Cervical Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Chinese Institute of Food Science and Technology, Food Science and Technology Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Sarcopenia has been identified as a potential predictor of poor prognosis in various types of cancer. However, the impact of pretreatment sarcopenia and the reduction of skeletal muscle mass during treatment on survival outcomes of patients with cervical cancer is still not well understood.

Objective

This meta-analysis was conducted to investigate the impact of pretreatment sarcopenia and treatment-associated muscle loss on survival outcomes in patients with cervical cancer. Data Sources The PubMed, EMBASE, Web of Science, and Cochrane Library databases were searched for studies exploring the relationship between muscle loss and the prognosis of cervical cancer until January 1, 2023. Data Extraction The hazard ratios (HRs) and 95% CIs for overall survival (OS) and progression-free survival (PFS) were extracted. Data Analysis The data were analyzed using R software. The studies’ quality was assessed using the Quality in Prognostic Studies tool. Twelve observational studies involving 1498 patients with cervical cancer were included in the analysis, with a prevalence of sarcopenia ranging from 24.8% to 57.5%. Sarcopenia was an independent predictor of poor OS (HR, 1.68; 95% CI, 1.28–2.21; P < .01) and PFS (HR, 1.53; 95% CI, 1.19–1.98; P < .01) in patients with cervical cancer. Additionally, the decrease in skeletal muscle during treatment was also significantly related to the OS (HR, 4.46; 95% CI, 2.87–6.94; P < .01) and PFS (HR, 2.89; 95% CI. 1.83–4.55; P < .01).

Conclusions

The prevalence of pretreatment sarcopenia was high among patients with cervical cancer. Pretreatment sarcopenia and skeletal muscle loss during treatment both negatively affected prognosis in cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaUterine Cervical NeoplasmsTomography, X-Ray ComputedHumansFemalePrognosisMuscle, Skeletal

Stichwörter der Autor:innen

cervical cancermeta-analysisprognosissarcopeniasurvival

Autor:innen und Institutionen

  • Department of Clinical Nutrition, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, China.
  • Department of Abdominal Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, China.
  • Department of Gynecology and Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, China.
  • Nursing Department, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430079, China.

ORCID-Profile: Xin Jin

Förderung

  • Chinese Institute of Food Science and Technology
  • Food Science and Technology Foundation

Zitieren

APA

Tian, M., Xu, H., Wang, H., Wang, H., Dai, Z., Ding, C., Guo, H., & Jin, X. (2025). Pretreatment Computed Tomography–Defined Sarcopenia, Treatment-Associated Muscle Loss, and Survival in Patients With Cervical Cancer: A Systematic Review and Meta-Analysis. Nutrition Reviews, 83(5), 797-808. https://doi.org/10.1093/nutrit/nuae130

Vancouver

Tian M, Xu H, Wang H, Wang H, Dai Z, Ding C, et al. Pretreatment Computed Tomography–Defined Sarcopenia, Treatment-Associated Muscle Loss, and Survival in Patients With Cervical Cancer: A Systematic Review and Meta-Analysis. Nutrition Reviews. 2025;83(5):797-808. doi:10.1093/nutrit/nuae130

BibTeX
@article{Tian2025,
  author = {Tian, Mengxing and Xu, Huiting and Wang, Hongbin and Wang, Huifen and Dai, Zhu and Ding, Chenchen and Guo, Huan and Jin, Xin},
  title = {Pretreatment Computed Tomography–Defined Sarcopenia, Treatment-Associated Muscle Loss, and Survival in Patients With Cervical Cancer: A Systematic Review and Meta-Analysis},
  journal = {Nutrition Reviews},
  year = {2025},
  volume = {83},
  number = {5},
  pages = {797--808},
  doi = {10.1093/nutrit/nuae130}
}
Kostenlos starten →